Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine Business Wire Nawigacja wpisu Clinical Endpoints and data management in the era of ophthalmic precision medicine – Open Access Government Voluntary Faculty Contributions to Department of Internal Medicine – Yale School of Medicine
